Curaleaf Holdings (CURLF) Receivables - Other (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Receivables - Other of $5.1 million for Q4 2025, up 6.91% year-on-year from $4.8 million in Q4 2024, and up 6.91% on a QoQ basis from $4.8 million in Q4 2024.

Curaleaf Holdings (CURLF) Receivables - Other (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Receivables - Other for 7 consecutive years, with $5.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Receivables - Other rose 6.91% year-over-year to $5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.1 million (up 6.91% YoY) and the FY2025 annual result came in at $5.1 million, up 6.91% from the prior year.
  • Receivables - Other grew to $5.1 million in Q4 2025 per CURLF's latest filing, from $4.8 million in the prior quarter.
  • Over the last five years, Receivables - Other for CURLF reached as high as $5.8 million in Q4 2021 and fell as low as -$33.8 million in Q1 2021.
  • A 5-year average of -$1.8 million and a median of $4.8 million in 2022 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2021 — Receivables - Other soared 136.62% — and 2023, when it tumbled 50.42%.
  • Year by year, Receivables - Other stood at $5.8 million in 2021, then retreated by 17.13% to $4.8 million in 2022, then slumped by 50.42% to $2.4 million in 2023, then jumped by 100.21% to $4.8 million in 2024, then increased by 6.91% to $5.1 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods registered $5.1 million, $4.8 million, and $2.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.09 Mn
Dec 31, 2025 5.09 Mn
Dec 31, 2024 4.76 Mn
Dec 31, 2024 4.76 Mn
Dec 31, 2023 2.38 Mn
Dec 31, 2023 2.38 Mn
Dec 31, 2022 4.80 Mn
Dec 31, 2022 4.80 Mn
Dec 31, 2021 5.79 Mn
Dec 31, 2021 5.79 Mn
Mar 31, 2021 -33.75 Mn
Mar 31, 2021 -33.75 Mn
Dec 31, 2020 2.45 Mn
Dec 31, 2020 2.45 Mn
Sep 30, 2020 -37.06 Mn
Sep 30, 2020 -37.06 Mn
Dec 31, 2019 996,000.00
Dec 31, 2019 996,000.00